| 2025-11-26 |
详情>>
内部人交易：
Montgomery Gwendolyn Ann股份减少40996.00股
|
| 2025-10-29 |
详情>>
股本变动：
变动后总股本25828.04万股
|
| 2025-10-29 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.78美元,归母净利润2.00亿美元,同比去年增长26.41%
|
| 2025-10-29 |
财报披露：
美东时间 2025-10-29 盘前发布财报
|
| 2025-07-30 |
详情>>
业绩披露：
2025年中报每股收益0.46美元,归母净利润1.19亿美元,同比去年增长7.05%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益0.24美元,归母净利润6200.00万美元,同比去年增长55.00%
|
| 2025-04-17 |
股东大会：
将于2025-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees identified in the proxy statement following this Notice (“Proxy Statement”).
2.To conduct an advisory vote to approve named executive officer (“NEO”) compensation.
3.To conduct an advisory vote on the frequency of future advisory votes to approve NEO compensation.
4.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) contained in Appendix A of the Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
5.To approve the Company’s directors’ remuneration policy (the “Directors’ Remuneration Policy”) as contained in Appendix A of this Proxy statement in accordance with the requirements of the Companies Act
6.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 3, 2026.
7.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid).
8.To authorize the audit committee (the “Audit Committee”) of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
9.To authorize the Board to allot equity securities in the Company.
10.Subject to the passing of Proposal 9, to authorize the Board to allot equity securities without pre-emptive rights.
|
| 2025-02-06 |
详情>>
业绩披露：
2024年年报每股收益0.75美元,归母净利润1.95亿美元,同比去年增长-16.32%
|
| 2025-02-06 |
详情>>
业绩披露：
2022年年报每股收益0.78美元,归母净利润2.21亿美元,同比去年增长-25.68%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.61美元,归母净利润1.58亿美元,同比去年增长-6.88%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益0.42美元,归母净利润1.11亿美元,同比去年增长21.25%
|
| 2024-07-31 |
详情>>
业绩披露：
2023年中报每股收益0.33美元,归母净利润9130.00万美元,同比去年增长8.69%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益0.15美元,归母净利润4000.00万美元,同比去年增长51.52%
|
| 2024-04-26 |
股东大会：
将于2024-06-20召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees identified in the proxy statement following this Notice (“Proxy Statement”).
2.To conduct an advisory vote to approve named executive officer (“NEO”) compensation.
3.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) contained in Appendix A of the Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
4.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 28, 2024.
5.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid).
6.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
7.To approve the forms of share repurchase contracts attached in Appendix B and Appendix C of the Proxy Statement and repurchase counterparties.
8.To authorize the Board to allot equity securities in the Company.
9.Subject to the passing of Proposal 8, to authorize the Board to allot equity securities without pre-emptive rights.
|
| 2024-02-08 |
详情>>
业绩披露：
2023年年报每股收益0.86美元,归母净利润2.33亿美元,同比去年增长5.48%
|
| 2023-11-03 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.62美元,归母净利润1.70亿美元,同比去年增长25.09%
|
| 2023-04-26 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees identified in the proxy statement following this Notice (“Proxy Statement”).
2.To conduct an advisory vote to approve named executive officer compensation.
3.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) contained in Appendix A of the Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
4.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 30, 2023.
5.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company’s shareholders).
6.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
7.To transact such other business as may properly come before the AGM or any adjournment thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-09召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees identified in this Proxy Statement.
2.To conduct an advisory vote to approve named executive officer compensation.
3.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) (excluding the Directors’ Remuneration Policy (as defined below)) contained in Appendix A of this Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
4.To approve the Company’s directors’ remuneration policy (the “Directors’ Remuneration Policy”) as contained in Appendix A of this Proxy statement in accordance with the requirements of the Companies Act.
5.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022.
6.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company’s shareholders).
7.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
8.To transact such other business as may properly come before the AGM or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-27 |
股东大会：
将于2021-06-17召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees identified in this Proxy Statement.
2.To conduct an advisory vote to approve named executive officer compensation.
3.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) contained in Appendix A of this Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
4.To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending January 1, 2022.
5.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company’s shareholders)
6.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
7.To transact such other business as may properly come before the AGM or any adjournment thereof.
|
| 2020-04-01 |
股东大会：
将于2020-05-14召开股东大会
会议内容 ▼▲
- 1.To elect the seven director nominees identified in this Proxy Statement.
2.To conduct an advisory vote to approve named executive officer compensation.
3.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) contained in Appendix A of this Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
4.To ratify the appointment of Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm for the year ending January 2, 2021.
5.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company’s shareholders).
6.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
7.To transact such other business as may properly come before the AGM or any adjournment thereof.
|
| 2019-08-28 |
股东大会：
将于2019-10-07召开股东大会
会议内容 ▼▲
- 1.To approve the form of share repurchase contracts and repurchase counterparties.
2.To approve an amendment to the Company’s Articles of Association to authorize the issuance of a new class or classes of shares, including preference shares, subject to the limit on the authority of the Board of Directors to allot new shares of the Company set forth therein and make other non-substantive changes.
3.To transact such other business as may properly come before the GM or any adjournment thereof.
|
| 2019-08-07 |
复牌提示：
2019-08-07 10:46:15 停牌，复牌日期 2019-08-07 10:51:24
|
| 2019-04-10 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the eight director nominees identified in this Proxy Statement.
2.To conduct an advisory vote to approve named executive officer compensation.
3.To conduct an advisory vote on the frequency of future advisory votes to approve named executive officer compensation.
4.To conduct an advisory vote on the Company’s directors’ remuneration report (the “Directors’ Remuneration Report”) (excluding the Directors’ Remuneration Policy (as defined below)) contained in Appendix A of this Proxy Statement in accordance with the requirements of the United Kingdom (the “U.K.”) Companies Act 2006 (the “Companies Act”).
5.To approve the Company’s directors’ remuneration policy (the “Directors’ Remuneration Policy”) contained in Appendix A of this Proxy Statement in accordance with the requirements of the Companies Act.
6.To ratify the appointment of Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm for the year ending December 28, 2019.
7.To re-appoint Deloitte LLP as the Company’s U.K. statutory auditor under the Companies Act (to hold office until the conclusion of the next annual general meeting at which accounts are laid before the Company’s shareholders).
8.To authorize the Audit Committee of the Board of Directors of the Company (the “Board” or “Board of Directors”) to determine the remuneration of Deloitte LLP in its capacity as the Company’s U.K. statutory auditor.
9.To authorize the Board of Directors, in accordance with section 551 of the Companies Act, to exercise all the powers of the Company to allot deferred shares in the Company (the “Deferred Shares”) up to an aggregate nominal amount equal to the amount standing to the credit of the Company’s merger reserve.
10.To authorize, conditional on resolution 9 above being passed, the Board of Directors to capitalize a sum not exceeding the amount standing to the credit of the Company’s merger reserve, and to apply such sum in paying up in full the Deferred Shares and to allot such number of Deferred Shares as shall have an aggregate nominal value equal to such amount.
11.To approve the reduction of the share capital of the Company by the cancelling and extinguishing of all of the Deferred Shares.
12.To approve, for the purpose of creating distributable reserves, the cancellation of the balance standing to the credit of the Company’s share premium account.
13.To approve an amendment to the Company’s Articles of Association to allow for general meetings to be held virtually.
14.To authorize the Company and its subsidiaries, in accordance with sections 366 and 367 of the Companies Act, to make political donations and expenditures.
15.To transact such other business as may properly come before the AGM or any adjournment thereof.
|